Oral tolerance in the absence of naturally occurring Tregs

Journal of Clinical Investigation

Volumn 115, Issue 7, 2005, Pages 1923-1933

  Mucida, Daniel ^a,b   Kutchukhidze, Nino ^a   Erazo, Agustin ^a   Russo, Momtchilo ^b   Lafaille, Juan J ^a   Curotto De Lafaille, Maria A ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

FOOD ANTIGEN; IMMUNOGLOBULIN E; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA;

ALLERGY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; ASTHMA; CONTROLLED STUDY; EFFECTOR CELL; GERMINAL CENTER; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; MOUSE; NONHUMAN; ORAL TOLERANCE; PNEUMONIA; PRIORITY JOURNAL; T LYMPHOCYTE; TH2 CELL; TREG CELL;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS; ASTHMA; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; DNA, COMPLEMENTARY; IMMUNE TOLERANCE; IMMUNITY, MUCOSAL; INJECTIONS, INTRAPERITONEAL; JOB'S SYNDROME; LUNG; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NEUTRALIZATION TESTS; OVALBUMIN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA;

EID: 22144479379     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI24487     Document Type: Article

References (70)

1. Vaz, N.M., et al. 2000. The conservative physiology of the immune system. Braz. J. Med. Biol. Res. 36:13-22.
2. Faria, A.M.C., and Weiner, H.L. 1999. Oral tolerance: mechanisms and therapeutic applications. Adv. Immunol. 73:153-264.
3. Wu, I.L.Y., and Weiner, H.L. 2003. Oral tolerance. Immunol. Res. 28:265-284.
4. Mayor, L., and Shao, L. 2004. Therapeutic potential of oral tolerance. Nat. Rev. Immunol. 4:407-419.
5. Chen, Y., et al. 1995. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature. 376:177-180.
6. Gutgemann, I., Fahrer, A.M., Altman, I.D., Davis, M.M., and Chien, Y.H. 1998. Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen. Immunity. 8:667-673.
7. McMenamin, C., McKersey, M., Kahnlein, P., Hunig, T., and Holt, P.G. 1995. Gamma delta T cells down-regulate primary IgE responses in cars to inhaled soluble protein antigens. J. Immunol. 154:4390-4394.
8. Alpan, O., Bachdder, E., Isil, E., Arnheiter, H., and Matzinger, P. 2004. 'Educated' dendritic cells act as messengers from memory to naive T helper cells. Nat. Immunol. 5:615-622.
9. Van Houten, N., and Blake, S.F. 1996. Direct measurement of anergy of antigen-specific T cells following oral tolerance induction. J. Immunol. 157:1337-1341.
10. Zhang, X., Izikson, L., Lia, L., and Weiner, H.L. 2001. Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration. J. Immunol. 167:4245-4253.
11. Hauet-Broere, F., et al. 2003. Functional CD25-and CD25+ mucosal regulatory T cells are induced in gut-draining lymphoid tissue within 48 h after oral antigen application. Eur. J. Immnnol. 33:2801-2810.
12. Chen, Y., and Ma, Y. 2002. Roles of cytotoxic T-lymphocyte-associaced antigen-4 in the inductive phase of oral tolerance. Immunology. 105:171-180.
13. Fowler, S., and Powrie, F. 2002. CTLA-4 expression on antigen-specific cells hut not IL-10 secretion is required for oral tolerance. Eur. J. Immunol. 32:2997-3006.
14. Thorstenson, K.M., and Khoruts, A. 2001. Generation of anergic and potentially immunoregulatory CD25(+)CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J. Immunol. 167:188-195.
15. Unger, W. W., et al. 2003. Early events in peripheral regulatory T cell induction via the nasal mucosa. J. Immunol. 171:4592-4603.
16. Dubois, R., et al. 2003. Innate CD4+CD25+ regulatory T cells are required fur oral tolerance and inhibition of CD8+ T cells mediating skin inflammation. Blood. 102:3295-3301.
17. Ostroukhova, M., et al. 2004. Tolerance induced by inhaled antigen involves CD4(+) T cells expressing membrane-bound TGF-β and FOXP3. J. Clin. Invest. 114:28-38. doi:10.1172/JCI200420509.
18. Faria, A.M., et al. 2003. Oral tolerance induced by continuous feeding: enhanced lip-regulation of transforming growth factor-beta/interleukin-10 and suppression of experimental autoimmune encephalomyelitis. J. Autoimmun. 20:135-145.
19. Lafaille, J.J., Nagashima, K., Karsuki, M., and Tonegawa, S. 1994. High incidence of spontaneous autoimmune encephalomyelitis in immuno-deficient anti-myelin basic protein T cell receptor transgenic mice. Cell. 78:399-408.
20. Apostolou, I., and von Boehmer, II. 2004. In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 199:1401-1408.
21. Cobbold, S.P., et al. 2004. Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants. J. Immunol. 172:6003-6010.
22. Curotto de Lafaille, M.A., Lino, A.C., Kutchukhidze, N., and Lafaille, J.J. 2004. CD25-T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion. J. Immunol. 173:7259-7268.
23. Stock, P., et al. 2004. Induction of T helper type I-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity. Nat. Immunol. 5:1149-1156.
24. Ghen, C., Lee, W.U., Yun, P., Snow, P., and Liu, C.P. 2003. Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes. J. Immunol. 171:733-744.
25. Sundstedt, A., O'Neill, E.J., Nicolson, K.S., and Wraith, D.C. 2003. Role for IL-10 in suppression mediated by pepride-indueed regulatory T cells in vivo. J. Immunol. 170:1240-1248.
26. Vieira, P.L., et al. 2004. IL-10-secreting regulatory T cells do not express Foxp3 bue bave comparable regulatory function to naturally occurring CD4-J-CD25+ regulatory T cells. J. Immunol. 172:5986-5993.
27. Bynoe, M.S., Evans, J.T., Viret, C., and Janeway C.A., Jr, 2003. Epicutaneous immunization with antoantigenic peptides induces T suppressor cell that prevent experimental allergic encephalomyelitis. Immunity. 19:317-328.
28. Chen, Y., Kuchroo, V., Inobe, J., Hafler, D.A. and Weiner, H.L. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encepbalomyelites. Science. 265:1237-1240.
29. Chen, W., et al. 2003. Conversion of peripheral CD4+CD2S- naive T cells to CD4+CD2S+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198:1875-1886.
30. Fantim, M.C., et al. 2004. Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and dovvn-regulation of Smad7. J. Immunol. 172:5149-5153.
31. Park, H.B., Paik, D.J., Jang, E., Hong, S., and Young, J. 2004. Acquisition of anergic and suppressive activities in transforming growth factor-beta-costimulated CD4+CD25- T cells. Int. Immunol. 16:1203-1213.
32. Curotto de Lafaille, M.A., et al. 2001. Hyper immunoglobulin E response in mice with monoclona populations of B and T lymphocytes. J. Exp. Med. 194:1349-1359.
33. lo thymocytes in vivo. Science. 250:1720-1723.
34. Momhaerts, P., et al. 1992. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68:869-877.
35. Russo, M., et al. 2001. Suppression of asthma-like responses in different mouse strains by oral tolerance. Am. J. Respir. Cell Mol. Biol. 24:518-526.
36. Russo, M., et al. 1998. Prevention of lung cosinephilic inflammation by oral tolerance. Immune. Lett. 61:15-23.
37. Bottomly, K., et al. 1989. A monoclonal antibody to murine CD45R distinguishes CD4 T cell populations that produce different cytokines. Eur. Immunol. 19:617-623.
38. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. and Toda, M. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL receptor alpha-chains (CD25). Breakdown of single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151-1164.
39. Read, S., Malmstrom, V., and Powrie, F. 2000. Cytotoxic T lymphocyte-associated antigen 4 play an essential role in the function of CD25(+)CD4(+) regularory cells that control intestinal inflammation. J. Exp. Med. 192:295-302.
40. Annacker, O., et al. 2001. CD25+ CD4+ T cell regulate the expansion of peripheral CD4 T cell through the production of IL-10. J. Immunol. 166:3008-3018.
41. Hori, S., Nomura, T., and Sakaguchi, S. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science. 299:1057-1061.
42. Foncenot, J.D., Gavin, M.A., and Rudensky, A.Y. 2003. Foxp3 programs the development and function of CD4(+)CD25(+) regulatory T cells. Natl. Immunol. 4:330-336.
43. Khartri, R., Cox, T., Yasayko, S.A., and Radmell, F. 2003. An essential role for Scurfin in CD4(+)CD25(+) T regulatory cells. Nat. Immunol. 4:337-342.
44. Piccirillo, C.A., and Shevach, E.M. 2004. Naturally occurring CD4+CD25+ immunoregulatory T cell central players in ehe arena of peripheral tolerance Semin. Immunol. 16:81-88.
45. Read, S., and Powrie, F. 2001. CD4(+) regulatory cells. Curr. Opin. Immunol. 13:644-649.
46. Curotto de Lafaille, M.A., and Lafaille, J.J. 2002. CD4(+) regulatory T cells in autoimmunity an allergy. Curr. Opin. Immunol. 14:771-778.
47. Weiner, H.L. 2001. Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells. Microbes Infect. 3:947-954.
48. Mowat, A.M. 2003. Anatomical basis of tolerant and immunity to intestinal antigens. Nat. Rev. Immunol. 3:331-341.
49. Colin, L., Tepper, J.S., and Bottomly, K. 1998. IL-4 independent induction of airway hyperresponsiveness by Th2, but not Th1, cells. J. Immunol. 161:3813-3816.
50. Takaoka, A., et al 2001. A critical role for mouse CXC chemokine(s) in pulmonary neutrophilia during Th type 1-dependent airway inflammation. J. Immunol. 167:2349-2353.
51. Sawicka, E., et al. 2003. Inhibition of Th 1- and Th2-mediated airway inflammation by the sphingosine 1-phosphate receptor agonist FTY720. J. Immunol. 171:6206-6214
52. Moore, K.W., de Waal Malefyt, R., Coffman, R.L. and O'Garra, A. 2001. Interleukin-10 and the interleukin-10 receptor [review]. Annu. Rev. Immunol. 19:683-765.
53. Samsom, J.N. 2004, Regulation of antigen-specific regulatory T-cell induction via nasal and oral mucosa. Crit. Rev. Immunol. 24:157-177.
54. Mattingly, J.A., and Waksman, B.H. 1978. Immunologic suppression after oral administration of antigen. I. Specific suppressosr cells formed in rat Peyer's patches after oral administration of sheep erythrocytes and their systemic migration. J. Immunol. 121:1878-1883.
55. Richman, L.K., Chiller, J.M., Brown, W.R., Hanson, O.G., and Vax, N.M. 1978. Enterically-induced immunological tolerance. I. Induction of suppressor T cells by in tragas trie administration of soluble proteins. J. Immunol. 212:2429-2435.
56. Zhang, X., Izikson, L., Liu, L., and Weiner, H.L. 2001. Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration. J. Immunol. 167:4245-4253.
57. Kobets, N., Kennedy, K., and Garside, P. 2003. An investigation of the distribution of antigen fed in tolerogenic or immunogenic forms. Immunol. Lett. 88:147-155.
58. Rizzo, L.V., et al. 1999. IL-4 and IL-10 are both required for the induction of oral tolerance. J. Immunol. 162:2613-2622.
59. Akbari, O., DeKruyff, R.H., and Umetsu, D.T. 2001. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2:725-731.
60. Miller, A., Lider, O., Roberts, A.B., Sporn, MB., and Weiner, H.L. 1992. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vivo and in vitro immune response by the release of transforming growth factor beta after antigen-specific triggering. Prof. Natl. Acad. Sci. U. S. A. 89:421-425.
61. Fukaura, H., et al. 1996. Induction of circulating myelin basic protein and proceolipid protein-specific transforming growth factor-beta β-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J. Clin. Invest. 98:70-77.
62. Barone, K.S., Tolarova, D.D., Ormsby, I., Doetschman, T., and Michael, J.G. 1998. Induction of oral tolerance in TGF-beta 1 null mice. J. Immunol. 161:154-160.
63. Walker, M.R., et al. 2003. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J. Clin. Invest. 112:1437-1443. doi:10.1172/JCI200319441.
64. Zbeng, S.G., Gray, J.D., Ohtsuka, K., Yamagiwa, S., and Horwitz, D.A. 2002. Generation ex vivo of TGF-beta-prodticing regulatory T cells from CD4(+)CD25(+) precnrsors. J. Immunol. 169:4183-4189.
65. Piccirillo, C.A., et al. 2002. CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta I production and responsiveness. J. Exp. Med. 196:237-246.
66. Huber, S., et al. 2004. Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+T cells. J. Immunol. 173:6526-6531.
67. Schramm, C., et al. 2004. TGFbeta regulates the CD4+CD25+ T-cell pool and the expression of Foxp3 in vivo. Int. Immunol 16:1241-1249.
68. Peng, Y., Laouar, Y., Li, M.O., Green, E.A., and Flavell, R.A. 2004. TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes. Proc. Natl. Acad. Sci. U. S. A. 101:4572-4577.
69. Furtado, G.C., Curotto de Lafaille, M.A., Kutchukhidxe, N., and Lafaille, J.J. 2002. Interleukin 2 signaling is required for CD4(+) regulatory T cell function. J. Med. 196:851-857.
70. Antov, A., Yang, L., Vig, M., Baltimore, D., and Van Parijs, L. 2003. Essential role for STATS signaling in CD25-CD4+ regulatory T cell homeostasis and the maintenance of self-tolerance. J. Immunol. 171:3435-3441.